Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Molecular Diagnostics » OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises

OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises

Nov 12, 2020
|
staff reporter

NEW YORK – Lung cancer diagnostics firm OncoCyte said after the close of the market on Thursday that it posted $555,000 in revenues for the third quarter compared to none a year ago.

The Alameda, California-based firm beat the analysts' average estimate of $370,000.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Another Study for AstraZeneca

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna to Seek EUA

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

To Spot it Earlier

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

PLOS Papers on Glioblastoma in Lebanon, Syndromic Gene PheWAS, Newborn Cytokine GWAS

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.

Dec
03
Featured Webinar

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion. 

What's Popular?

In Molecular Diagnostics

  1. Grail Inks Deal With UK National Health Service to Offer Cancer Screening Blood Test in 2021

  2. European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer

    Premium

  3. BGI Bloodstream Pathogen Nucleic Acid Detection Kit Gets CE Mark

  4. Startup Angstrom Bio Plans Saliva-Based COVID-19 Nucleic Acid Test on Nanopore Sequencing Platform

    Premium

  5. Genetron Health, Wuxi Government Form Joint Venture for Liver Cancer Screening Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.